You've got male: Sex and the microbiota-gut-brain axis across the lifespan by Jaggar, Minal et al.
UCC Library and UCC researchers have made this item openly available.
Please let us know how this has helped you. Thanks!
Title You've got male: Sex and the microbiota-gut-brain axis across the
lifespan
Author(s) Jaggar, Minal; Rea, Kieran; Spichak, Simon; Dinan, Timothy G.; Cryan,
John F.
Publication date 2019-12-02
Original citation Jaggar, M., Rea, K., Spichak, S., Dinan, T. G. and Cryan, J. F. (2020)
'You've got male: Sex and the microbiota-gut-brain axis across the
lifespan', Frontiers in Neuroendocrinology, 56, 100815 (22pp). doi:
10.1016/j.yfrne.2019.100815





Access to the full text of the published version may require a
subscription.
Rights © 2019, Elsevier Inc. All rights reserved. This manuscript version is
made available under the CC BY-NC-ND 4.0 license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Embargo information Access to this article is restricted until 18 months after publication by
request of the publisher.






You’ve Got Male: Sex and the Microbiota-Gut Brain Axis Across the Life-
span




To appear in: Frontiers in Neuroendocrinology
Received Date: 12 July 2019
Revised Date: 16 October 2019
Accepted Date: 11 November 2019
Please cite this article as: M. Jaggar, K. Rea, S. Spicak, T.G. Dinan, J.F. Cryan, You’ve Got Male: Sex and the
Microbiota-Gut Brain Axis Across the Lifespan, Frontiers in Neuroendocrinology (2019), doi: https://doi.org/
10.1016/j.yfrne.2019.100815
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover
page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version
will undergo additional copyediting, typesetting and review before it is published in its final form, but we are
providing this version to give early visibility of the article. Please note that, during the production process, errors
may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
© 2019 Published by Elsevier Inc.
1
You’ve Got Male: Sex and the Microbiota-Gut Brain Axis Across 
the Lifespan
Minal Jaggar1, Kieran Rea1, Simon Spicak1,3, 
Timothy G. Dinan1,2, John F. Cryan1,3
1APC Microbiome Ireland, University College Cork, Cork, Ireland. 
2Department of Psychiatry and Neurobehavioural Science, University College Cork, Cork, 
Ireland.
3Department of Anatomy and Neuroscience, University College Cork, Cork, Ireland.
Invited Review: Frontiers in Neuroendocrinology
Issue title: Sex Differences in the Gut Microbiota and Mental Health
Article type: Review Article
*Corresponding author:  email: j.cryan@ucc.ie
2
Abstract 
Sex is a critical factor in the diagnosis and development of a number of mental health disorders 
including autism, schizophrenia, depression, anxiety, Parkinson’s disease, multiple sclerosis, 
anorexia nervosa and others; likely due to differences in sex steroid hormones and genetics. 
Recent evidence suggests that sex can also influence the complexity and diversity of microbes 
that we harbour in our gut; and reciprocally that our gut microbes can directly and indirectly 
influence sex steroid hormones and central gene activation. There is a growing emphasis on 
the role of gastrointestinal microbiota in the maintenance of mental health and their role in the 
pathogenesis of disease. In this review, we introduce mechanisms by which gastrointestinal 
microbiota are thought to mediate positive health benefits along the gut-brain axis, we report 
how they may be modulated by sex, the role they play in sex steroid hormone regulation, and 
their sex-specific effects in various disorders relating to mental health. 
Keywords: microbiota-gut-brain axis, microbiome, sex difference, mental disorders, 
antibiotic, neurological disorders, germ-free.
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1 Introduction
Most major neuropsychiatric and neurological disorders exhibit skewed male to female 
prevalence ratio. While neurodevelopmental disorders such as autism spectrum disorder 
(ASD), attention deficit hyperactivity disorder, early onset schizophrenia, and Parkinson’s 
disease are more common in males; mood disorders such as anxiety, depression, anorexia 
nervosa, post-traumatic stress disorder, and multiple sclerosis are more frequent in females 
[(McCarthy et al. 2017), Fig. 1]. In addition to factors such as genetic makeup, life experience, 
socioeconomic status, physiological state, and perceived stress levels, recent clinical and 
animal studies emphasize the role of gut microbiota in the neurobiology of mental disorders 
with specific differences observed in males and females (J. J. Chen et al. 2018a; Clarke et al. 
2013; Huang et al. 2019; Jasarevic et al. 2017; Vemuri et al. 2019). While the contributions of 
many of these factors on neuropsychiatric and neurological disorders, including the gut 
microbiota and microbiota-gut-brain axis, have been extensively reviewed elsewhere (Cenit et 
al. 2017a; Jasarevic et al. 2016; Kelly et al. 2017a; Luczynski et al. 2016); the complex 
interaction between sex, microbiota-gut-brain communication and changes in mood and 
behaviour have been poorly addressed. In this review we will introduce mechanisms by which 
the microbiota can influence mood and behaviour, discuss the effect of sex on microbiota 
diversity and complexity in health and disease, and further interrogate how the microbiota can 
influence sex hormones and reciprocally how sex hormones can influence microbiota.
2 The Gastrointestinal Microbiota
On-going collaborative efforts including the Human Microbiome Project (HMP) (Human 
Microbiome Project 2012), MetaHIT (Qin et al. 2010), American Gut Project (McDonald et al. 
2018), British Gut Project (Jackson et al. 2018), as well as important gut microbiome analyses 
(Falony et al. 2016; Zhernakova et al. 2016) have been instrumental in surveying and 
describing the gut microbiota at a population level. The human gastrointestinal tract harbours 
a complex and dynamic microbial ecosystem composed of bacteria, archaea, yeasts, single-
celled eukaryotes, as well as helminthic parasites and viruses, including bacteriophage (Human 
Microbiome Jumpstart Reference Strains et al. 2010). Of the microbiota consortia, the bacteria 
are the most widely studied. Current combined HMP and MetaHIT data estimate that there are 
at least 2776 prokaryotic species that have been isolated from human faecal matter (Bilen et al. 
2018). These have been classified into 11 different phyla with Proteobacteria, Firmicutes, 
Actinobacteria and Bacteroidetes comprising over 90% of the prokaryotic microbiome, while 
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Fusobacteria and Verrucomicrobia phyla are present in low abundance (Eckburg et al. 2005; 
Hugon et al. 2015; J. Li et al. 2014).
Further, everyone has a unique microbiota signature, established early in the first years of life, 
shaped by a number of factors including: mode of delivery (vaginal or C-section) (Fouhy et al. 
2019; Wampach et al. 2018), whether breast-fed or formula-fed (Hill et al. 2017; Madan et al. 
2016; Stewart et al. 2018), sex (Jasarevic et al. 2016; Markle et al. 2013; Wallis et al. 2016), 
genetics (Bonder et al. 2016), diet (Gentile and Weir 2018), medication (in particular antibiotic 
medication) (Cho et al. 2012; Cussotto et al. 2019; Le Bastard et al. 2018; Leclercq et al. 2017; 
Maier et al. 2018), exposure to viral or bacterial infections (Escobar et al. 2011; Estes and 
McAllister 2016; Karst 2016), and stress (Foster et al. 2017; Rea et al. 2016). Over millennia, 
we have co-evolved with our microbiota, becoming mutually co-dependent for survival 
(Bordenstein and Theis 2015; Gaulke et al. 2018). Under normal homeostatic condition, this 
microbial population plays a key role in metabolism, intestinal peristalsis, mucosal integrity, 
pH balance, immune priming and protection against invading pathogens (Hyland and Cryan 
2016). Since our brains constantly receive signals from the gut, the relationship between the 
host and its microbiota along the microbiota-gut-brain axis from a general health and health 
maintenance perspective cannot be overlooked.
Genes within the human gut microbiota significantly outnumber host human genes 100:1 and 
are capable of producing a plethora of centrally acting compounds, influencing virtually all 
aspects of human physiology and biology (Goodrich et al. 2017; Rosenberg and Zilber-
Rosenberg 2018). While our inherited genome is essentially stable for the lifetime of the host, 
the microbiome is immensely diverse, dynamic, and responsive to external input, enhancing its 
potential as a target for therapeutic intervention (Flowers and Ellingrod 2015). 
2.1 Bioactive Microbial metabolites
The different bacteria in our gut are capable of synthesising and releasing neurotransmitters 
and neuropeptides including catecholamines, GABA, histamine, choline and acetylcholine, 
that may mediate local physiological effects (including influencing motility and permeability) 
or enter the bloodstream to potentially influence centrally mediated events (Lyte 2014; Mittal 
et al. 2017). Many bacteria secrete bacteriocins, antibiotic peptides that inhibit the growth of 
other bacteria in the vicinity, thus self-regulating and preventing over-domination of any one 
species (Derrien and van Hylckama Vlieg 2015; Kommineni et al. 2015). Bacteria residing in 
the colon utilise fibres indigestible by the host as a nutritional substrate resulting in the 
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production of branched chain amino acids or the short-chain fatty acids butyrate, propionate, 
lactate and acetate predominantly (Baxter et al. 2019). These fatty acids can readily penetrate 
the intestines to activate their free fatty acid receptors on gut, lymph, immune cells and tissues; 
while evidence suggests they can mediate epigenetic events, possess neuroactive properties, 
and can regulate microglia density, morphology and maturation (Dalile et al. 2019; Huuskonen 
et al. 2004; Paul et al. 2015). Bacteria also facilitate the breakdown of dietary compounds 
through bile acid (BA) metabolism (Just et al. 2018). BAs are best known for facilitating the 
absorption of dietary lipids and lipid-soluble vitamins from the gut lumen. Certain bacterial 
taxa possess bile salt hydrolase activity (Lactobacillus) to carry out deconjugation of primary 
BAs from taurine or glycine, while other bacteria (Clostridium) are capable of transforming 
unconjugated primary BAs into secondary BAs as a result of 7α-dehydroxylation activity 
(Jones et al. 2008; Ridlon et al. 2014). The bacteria in the lumen of the gut mediate all these 
effects, without any direct interaction with host cells.
2.2 Microbiota-Gut communication
The lining of the gut is composed of a single-cell layer of epithelial cells held together by tight 
junction protein complexes, and contains predominantly enterocytes, secretory cells and gut 
associated lymphoid tissue (GALT), all coated with a mucus layer to create a physical barrier 
that separates host cells from luminal microbiota (Chelakkot et al. 2018). This dynamic 
structure has many functions including regulating the absorption of nutrients and fluid from 
the lumen of the intestines and to serve as a physical barrier to existing commensal bacteria, 
invading pathogens or harmful substances (Chelakkot et al. 2018). The exchange of molecules 
through the mucous layer and epithelium (often through tight junction proteins) serve to 
facilitate communication between the gut and the immune system through the recognition of 
self and non-self antigens, and maintains a healthy resting inflammatory tone that facilitates 
communication along the gut-brain axis (Kelly et al. 2015). The enterocytes express innate 
immune receptors and can release cytokines and chemokines, while the GALT utilise 
lymphocytes to mount a more specific immune response to microbial molecules including cell 
wall components, such as peptidoglycans (Royet et al. 2011). Epithelial pattern recognition 
receptors (PRRs) recognise molecular patterns unique to bacteria and other microorganisms 
(pathogen associated molecular patterns, or PAMPs) of which the Toll-like receptor family are 
the most studied, and once activated can recruit inflammatory mediators, cytokine production 
and chemokine-mediated recruitment of acute inflammatory cells (Duerkop et al. 2009). The 
secretory cells are responsible for the release of mucus from goblet cells, control of bacterial 
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diversity by antimicrobial secretion from Paneth cells (Ehmann et al. 2019; Salzman 2010), 
and in neuroendocrine control via the release from enteroendocrine cells of substances such as 
ghrelin, somatostatin, cholecystokinin, peptide YY and serotonin amongst others (Thaiss et al. 
2016).
Existing hypotheses suggest that these circulating cytokines, chemokines, endocrine 
messengers and microbial by-products can infiltrate the blood and lymphatic systems, or 
influence neural messages carried by the vagal and spinal afferent neurons to impact on 
centrally mediated events. Current research is involved in uncovering the underlying 
mechanisms by which these microbiome-influenced biomolecules impact brain, behaviour and 
mental health. 
2.3 The Microbiota-Gut-Brain Axis
The microbiome-gut-brain axis is a complex bi-directional system including the brain, the 
sympathetic and parasympathetic divisions of the autonomic nervous system, the endocrine 
and immune systems, the enteric nervous system, and the gut microbiome (C. R. Martin et al. 
2018). The microbiota can relay information about health status of the gut through endocrine 
(Cussotto et al. 2018), immune (Holzer et al. 2017; Soto et al. 2018; Thion et al. 2018b) and 
neuropeptide/neurotransmitter systems (Clarke et al. 2013; Lach et al. 2018; van Sadelhoff et 
al. 2019), the vagus nerve (Bravo et al. 2011; Fulling et al. 2019), and signalling molecules 
including short chain fatty acids (SCFA) (Dalile et al. 2019), branched chain amino acids (K. 
Gao et al. 2019b); bile moieties (Baars et al. 2018) and peptidoglycans (Arentsen et al. 2017). 
This in turn can profoundly impact on neuronal signalling in the brain and thus impact on 
emotional systems and behavioural response (C. R. Martin et al. 2018). 
3 Sex difference in the Brain
Mammalian brain shows characteristic region-specific sex differences at the level of anatomy, 
circuitry, activity, molecular profiles, and epigenetic modifications (Bakker 2019; Cosgrove et 
al. 2007; Nugent et al. 2015). Some of these differences are present at birth but can also emerge 
during puberty and modulated in adulthood. While overall brain metabolism is comparable 
between males and females, males have greater brain volume while females have greater 
cortical thickness (Ritchie et al. 2018). Controlling for brain volume, males have greater 
percentage of white matter while females have greater percentage of grey matter and cerebral 
blood flow in humans (Cosgrove et al. 2007). It is important to point that, while these sex-
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specific differences exist, a particular brain cannot be categorised as male or female brain, and 
any individual will have varying amounts of male and female brain characteristics (Joel 2011).
Females achieve peak cerebral volume at around 10 years while it is 14 years for males 
(Lenroot et al. 2007), which coincides well with average age of puberty indicating influence of 
sex steroid hormones. Sex hormonal contribution has been extensively studied in emergence 
of male and female physiological and behavioural traits in both, humans and animal models 
(Gillies and McArthur 2010; Juntti et al. 2010; Lu et al. 2019; Sato et al. 2004; Tsuda et al. 
2014). Sex hormones role in modulating immune responses is also well characterised with a 
predominant pro-inflammatory effect of oestrogens as oppose to an anti-inflammatory effect 
of testosterone (Klein and Flanagan 2016). At birth, the testosterone level in males is fifty 
percent higher compared to females with comparable oestrogen levels, as measured in the 
human cord blood (Mitsui et al. 2019). There is a surge of sex hormones in the first 6 months 
of life, which is thought to contribute to sex differences in the brain [(McCarthy 2016), Figure 
2]. 
Specific brain regions show sexual dimorphism at birth across several species, such as the 
sexually dimorphic nucleus of the preoptic area (SDN-POA) (larger in males, involved in male 
sexual behaviour), bed nucleus of stria terminalis (BNST) (larger in males, involved in 
sociosexual behaviour, mood, aggression, territoriality, and olfaction) and anteroventral 
periventricular nucleus (AVPV) (larger in females, regulate ovulatory cycle) (McCarthy et al. 
2017). These differences emerge during development and involve testosterone-mediated 
inhibition or activation of apoptosis (E. C. Davis et al. 1996; McCarthy et al. 2017; Tsukahara 
et al. 2006). The role for sex hormones is evident form animal studies showing neonatal 
androgen exposure to be necessary and sufficient for masculinization of the brain (Sato et al. 
2004; Wu et al. 2009). This is possibly due to increased aromatase activity responsible for 
conversion of testosterone to oestrogen, since oestrogen exposure to female neonates 
masculinizes their brain and behaviour (Wu et al. 2009). However, the direct role of androgens 
has also been reported using animal model with non-functional androgen receptor (Zuloaga et 
al. 2008). Oestrogens and androgens modulate synaptic plasticity and immune function, via the 
rapid response membrane receptors or cause transcriptional changes via the cytoplasmic 
receptor, thereby modulating neuronal circuits and behaviour [The following reviews can be 
referred to for more information on sex hormone receptor expression, proposed mechanisms, 
and sex differences in their function- (Baez-Jurado et al. 2019; Gillies and McArthur 2010; 
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McEwen and Milner 2017; Straub 2007)]. Postmenopausal oestrogen therapy in women have 
also shown promise with enhanced neuronal plasticity and improved cognition (Maki and 
Dumas 2009). While sex hormones drive a majority of these differences directly or indirectly, 
contribution of the sex chromosome at the cellular level in brain development has also been 
reported (Printzlau et al. 2017; Sekido 2014).
4 Sex differences in the Gut Microbiome across life
4.1 Human studies
Large population-wide studies fail to show any major sex-specific differences in the gut 
microbiota diversity, complexity or composition (Human Microbiome Project 2012; Mueller 
et al. 2006; Odamaki et al. 2016; Yatsunenko et al. 2012). However, based on community types 
categorised using clustering in stool samples from HMP consortium, females were more likely 
to show community type C (higher relative abundance of Ruminococcaceae, Faecalibacterium 
and Alistipes, lower relative abundance of Bacteroides and lack of Prevotella). Males were 
three times more likely to have community type D (higher relative abundance of Prevotella 
and lower relative abundance of Bacteroides) (Ding and Schloss 2014). The main findings of 
the articles reviewed on sex differences in microbiome composition is summarised in Table 1. 
There is now a growing interest in the role of sex differences in microbiome in the 
pathophysiology of a variety of diseases including cardiovascular diseases (Cross et al. 2018), 
diabetes (Markle et al. 2014), irritable bowel syndrome (Y. S. Kim and Kim 2018), obesity 
(Link and Reue 2017), and cancer (Jia and Xie 2018) among others.
Gut microbiota diversity increases in infancy and is stabilized by five years of age without any 
apparent sex-differences per se [(Avershina et al. 2014; Cheng et al. 2016), Figure 2]. At the 
taxa level, increased phylum Firmicutes and reduced Bacteroidetes profile is more common in 
girls along with increased colonization by Lactobacillus and Bifidobacterium in early infancy 
(Huda et al. 2019; R. Martin et al. 2016; Sordillo et al. 2017). This could disproportionately 
improve nutrient availability and gut barrier functions in females at this critical early window 
of brain development. Not many reports explore sex differences in gut microbiome profile 
during adolescence but in adults, alpha diversity increases slightly until middle age with greater 
microbiome diversity seen in females (de la Cuesta-Zuluaga et al. 2019). During middle-age, 
around the time of menopause, males and females have a steady alpha diversity up to 70 years 
after which there is a decline observed. There are no sex differences reported at this stage. The 
diversity rises in centenarians, which could be due to healthy ageing since frailty is associated 
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with reduce diversity (Claesson et al. 2012; van Tongeren et al. 2005). In adulthood, findings 
on microbiome composition report different taxa to be associated with sex but most studies 
agree with sex explaining a very small fraction of observed microbiome diversity at least in the 
healthy adult populations (Table 1). For example, comparisons at the species level in the Dutch 
cohort study report sex association with twelve microbial species (including Bilophila, 
Lachnospiraceae, and Bifidobacterium species) and 43 metabolic pathways (TCA cycle, 
gluconeogenesis, isoleucine biosynthesis, tryptophan degradation among others) (Sinha et al. 
2019). After multiple corrections, relative abundance of only Akkermansia muciniphila was 
higher in females. This bacterium has been associated with leanness and protection against 
diabetes and obesity, thus is of interest as a probiotic (Zhang et al. 2019).
In parallel to above observations, menopausal status also affects gut microbiome, with 
premenopausal women having higher abundance of SCFA producing bacteria compared to 
postmenopausal women and age-matched men (Santos-Marcos et al. 2018; Santos-Marcos et 
al. 2019). The SCFA producing genera Prevotella, Ruminococcus and Roseburia are reported 
to depend on sex and hormonal status. More direct correlation with oestradiol levels suggests 
a positive correlation for Gammaproteobacteria class and unknown family from Mixococcales 
(Proteobacteria- Lipopolysaccharide (LPS) producers), while bacterial family Prevotellaceae 
was negatively correlated (d'Hennezel et al. 2017; Santos-Marcos et al. 2018). This could 
increase LPS production and inflammation by Proteobacteria species, in addition to reduced 
SCFA production by Prevotellaceae in females, thereby increasing risk to mental disorders in 
the pubertal and reproductive phases. Oestrogen replacement therapy given to postmenopausal 
women increases vaginal Lactobacillus abundance and protect against infection (Muhleisen 
and Herbst-Kralovetz 2016), and has promising effect on mood and cognition (LeBlanc et al. 
2001; Zweifel and O'Brien 1997), but changes in gut microbiome needs to be addressed. 
Furthermore, oral contraceptives and ovariectomy are also associated with changes in gut 
microbiota (Sinha et al. 2019). Despite the role for female sex hormones in GI transit (Jung et 
al. 2003; Wald et al. 1981), clinical evidence for a change in gut microbiota composition across 
the menstrual cycle, or in response to contraceptive medication are very few. However, the 
vaginal microbiota is stable throughout the menstrual cycle in healthy Canadian women 
(Chaban et al. 2014). The human studies corroborate well with animal studies when it comes 
to sex-differences, but changes observed depend on species and strain [(Elderman et al. 2018), 
Table 1 and 2].
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4.2 Animal studies
Sex-differences in the mouse microbiota composition arise during puberty with the males 
acquiring a distinct gut microbiota composition compared to prepubertal mice of both sexes 
(Baars et al. 2018; Jasarevic et al. 2016; Yurkovetskiy et al. 2013). One study does report subtle 
sex-differences in gut microbiome composition postnatally and during weaning [(Jasarevic et 
al. 2017), Table 2]. The gut microbiota composition of adult SPF females resembles that of the 
prepubertal mice of both sexes (Yurkovetskiy et al. 2013). Conventionalised mice are also 
reported to have higher Firmicutes/Bacteroidetes ratio (marker for obesity) in females 
compared to males (Baars et al. 2018), similar to observations in humans. Treatment of female 
rats with Letrozole, an aromatase inhibitor, reduces oestradiol and progesterone levels while 
increasing testosterone and Luteinizing hormone levels (Guo et al. 2016). This led to increased 
Lactobacillus, Ruminococcus, Clostridium, and Prevotella without altering Bifidobacterium 
and Bacteroides. Prenatal exposure of androgen in female rats increased faecal relative 
abundance of steroid hormone synthesizing bacteria- Nocardiaceae and Clostridiaceae, 
bacteria associated with synthesis and elongation of unsaturated SCFAs, and lower abundance 
of Akkermansia, Bacteroides, Lactobacillus, and Clostridium (Sherman et al. 2018). 
Gonadectomy along with high fat diet was also associated with increased genera of 
Ruminococcaceae family in male mice of three different strains, and reduced Akkermansia 
genus in female mice (Org et al. 2016). This suggests that interaction of diet and sex hormone 
is crucial in alterations and maintenance of gut microbiota composition. Castration in male 
mice abolishes sexual difference of gut microbiota composition, suggesting a critical role for 
testosterone in the complexity and diversity of virile males (Yurkovetskiy et al. 2013). 
Oestrogens also regulate gut microbiota composition since beta diversity of ovariectomised 
(OVX) female mice clusters with male mice (Kaliannan et al. 2018). Further compositional 
analysis in the faecal microbiota of oestradiol treated males or OVX females show clustering 
with females, separate from male or OVX female cluster, suggesting the influence of oestrogen 
in modulating gut microbiota composition. Comparing the normal females to the OVX female 
or male groups revealed sex differences with lower Proteobacteria, reduced Bacteroides ratio 
and increased Bifidobacterium to Enterobacteriaceae ratio (Kaliannan et al. 2018). Some of 
these observations were recapitulated with 17-betaoestradiol treatments in males and OVX 
females. This study is conflicting with another report showing increased 
Firmicutes/Bacteroidetes ratio in adult female mice (Baars et al. 2018). Another study 
administering progesterone to OVX females report reduced anxiety and depressive-like 
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behaviour, along with increased Lactobacillus spp. in the gut (Sovijit et al. 2019). Both 
progesterone and Lactobacillus administration increased hippocampal Bdnf gene expression 
levels while antibiotic treatment abolished all these effects. In addition, in vitro analysis 
revealed positive effect of progesterone on the growth of L. reuteri (Sovijit et al. 2019). Thus, 
suggesting that sex hormones may directly influence specific gut microbial strains, which in 
turn modulate behaviour of the organism. 
With regards to oestrus cycle phase, gut microbiota seem largely unaltered in the murine model. 
However, Akkermansia was the only genus to vary depending on the oestrus phase (Wallace et 
al. 2018). Subcutaneous oestradiol implants in adult female mice increased bacterial diversity 
in a week, with elevated levels of Lactobacillaceae, Coriobacteriaceae and unidentified family 
from the Bacillales (Benedek et al. 2017). Supplementing the above findings on sex hormones, 
oestrogen receptor beta (expressed in the adult colon) knockout mice are reported to modulate 
gut microbiome composition, specifically the taxa Proteobacteria, Firmicutes and 
Bacteroidetes (Menon et al. 2013). These data provide clear evidence that sex hormones 
manipulate microbiota and may contribute towards sex-dependent gut microbiota differences, 
and associated changes with endocrine, immune and neurotransmitter systems across the 
lifespan, which needs to be further explored. 
While there exist sex differences in gut microbiota profile of adult humans and animals, the 
data is not unequivocal and deficient in early life and adolescent stages. In addition to assessing 
baseline sex differences on gut microbiome, it is crucial to uncover these differences in specific 
brain disorders, which will advance our understanding of sex biases in brain disorder 
prevalence, symptoms, and treatment. While several clinical studies associate gut microbiome 
changes in brain disorders, they often lack power to compare sex-differences and fewer animal 
studies exist in this regard, which are summarised below.
4.3 Gut Microbiota and Brain Disorders 
Clinical studies assessing the gut microbiota of patients with neuropsychiatric and neurological 
disorders report largely a reduction in overall abundance and diversity although there is much 
variability in terms of quality of studies and findings seen. Refer to cited reviews for details on 
gut microbiome and brain disorders [ASD- (Mayer et al. 2014; Srikantha and Mohajeri 2019), 
ADHD- (Cenit et al. 2017b), Schizophrenia- (Codagnone et al. 2019; Severance and Yolken 
2018), Parkinson’s disease- (Lubomski et al. 2019; Miraglia and Colla 2019), Anxiety- 
(Rackers et al. 2018), Depression- (Liang et al. 2018; Winter et al. 2018), Anorexia nervosa- 
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(Roubalova et al. 2019), PTSD- (Leclercq et al. 2016), Alzheimer’s disease- (Garcez et al. 
2019), MS- (Zoledziewska 2019)]. One study in MDD report reduced Bacteroidetes in males 
and increased Actinobacteria in females (J. J. Chen et al. 2018a). Another study on atypical 
antipsychotic treatment to bipolar patients reported reduced alpha diversity in females with no 
change observed in males (Flowers et al. 2019). There is some disparity in gut microbiota 
compositional changes for specific mental disorders, which may be attributed to differences in 
demographics, patient recruitment characteristics, diet of patients and healthy controls, method 
used for acquiring composition data and its statistical analysis. In clinical studies involving 
brain disorders and microbiome analysis, though sex is equally represented within study 
groups, sex-comparisons are mostly underexplored or not reported.
A more convincing evidence for a causal role of gut microbiota in mental disorders comes from 
recapitulation of mental disorder symptoms in rodents by mere transfer of the gut microbiota. 
This has been done for ASD (Sharon et al. 2019), MDD (Kelly et al. 2016; Zheng et al. 2016), 
anxiety associated with irritable bowel syndrome (De Palma et al. 2017), schizophrenia (Zheng 
et al. 2019), and Parkinson’s disease (Sampson et al. 2016). Limitations of these studies are 
that donor samples come solely from male human subjects and are then transferred into male 
animals, but no comparable study investigating the influence of human or animal faecal 
microbiota transplantation (FMT) from females has been conducted. In ASD gut microbiota 
transfer study, sex-differences only in behavioural outcome was assessed, wherein F1 male 
mice had greater detrimental effects on behaviour compared to females (Sharon et al. 2019). 
FMT from humans to animals does not exactly reproduce the gut microbiome of the human 
donor and bacterial species are colonized differently, thus questioning the ideal control and 
diseased human donor microbiome and the translatability of these studies.
Mouse models of mental disorders also report sex-specific alterations in the gut microbiota 
with pathological associations (Coretti et al. 2017; Jasarevic et al. 2017; Rincel et al. 2019). In 
the BTBR mouse model of ASD, Bacteroides, Parabacteroides, Sutterella, Dehalobacterium 
and Oscillospira genera were the main factors associated with behavioural alterations and 
enhanced intestinal permeability and inflammation (Coretti et al. 2017). Maternal separation 
with maternal unpredictable chronic stress in mice leads to sex-specific behavioural 
abnormalities and altered gut microbiome composition in adulthood of the offspring. The males 
exhibit social impairment along with abundance of taxa belonging to Lachnospiraceae and 
Porphyromonadaceae families unclassified Firmicutes, and Bacteroides, Lactobacillus and 
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Alloprevotella genera while females exhibit increased anxiety-like behaviour with limited gut 
microbiome alterations restricted to Lactobacillus and Mucispirillum genera (Rincel et al. 
2019). Prenatal stress exposure disrupts composition structure of Lactobacillus and 
Streptococcus in both sexes. Stress during gestation is also reported to abolish sex differences 
in the offspring gut microbiome with greater alterations in male pups (increased abundance of 
bacteria from family, Lachnospiraceae and Clostridiales) than female pups from the stressed 
dam (Jasarevic et al. 2017). 
Most clinical and animal studies lack sex comparisons of gut microbiota, and considering 
confounding factors arising due to sex; it is essential to understand the sex-dependent 
intricacies involved in mental disorders for efficacious sex-specific therapeutic approaches. 
The following section summarises studies addressing the effect of gut microbiome and sex on 
brain and behaviour (Table 3 and 4).
5 Sex- Microbiota-Gut-Brain interactions
It is clear that there can be much variability in microbiome studies in humans. This is often 
caused by several confounding factors such as genetics, diet, lifestyle, clinical history, 
hormonal levels, but studies are beginning to explore sex differences in gut microbiota-brain 
interactions (Table 3). Temperament in children and adults is associated with specific bacterial 
taxa, some of which depend on sex (Aatsinki et al. 2019; Christian et al. 2015; Taylor et al. 
2019). In a New Zealand cohort, antibiotic use in first year of life but not maternal antibiotic 
treatment is associated with increased neurocognitive difficulty and depression score up to age 
eleven (Slykerman et al. 2017a), however, sex-specific analysis was not carried out. In case of 
animal models of early life adversity (Coretti et al. 2017; Jasarevic et al. 2017; Rincel et al. 
2019; Thion et al. 2018b), males show greater emotional vulnerability over females, along with 
greater perturbation of the gut microbiota. The sex differences in the placental environment 
and inflammation status have been implicated in this bias (Kalisch-Smith et al. 2017; Thion et 
al. 2018a). Similarly, in a mouse model of multiple sclerosis, oestradiol treatment to female 
mice protected against autoimmune encephalomyelitis score and disease-induced gut 
microbiota and mucosal immune alterations (Benedek et al. 2017). 
While it is difficult to tease apart specific contribution of gut microbiota, genetics and sex, 
studies involving gut microbiota transfer across different strains suggest that gut microbiota 
dominate over genetic influence on the cortical transcriptional profile as well as behavioural 
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response in animals (Gacias et al. 2016). Environment also has a greater influence over host 
genetics in determining the human gut microbiome (Rothschild et al. 2018), which was 
elegantly reported in US immigration study with loss of gut microbiome diversity (Vangay et 
al. 2018). Keeping these confounding factors in mind, we have summarised the literature on 
contribution of gut microbiota in sex-dependent consequences of behavioural and 
physiological (Table 3 and 4) outcomes, largely assessed in animals.
5.1 Behavioural analyses
5.1.1 Germ-free studies
Several germ-free rodent studies report a reduced or no effect on anxiety-like phenotype in 
males and females [Summarised in (Vuong et al. 2017)]. Conflicting studies report opposite 
effects on locomotor and rearing behaviour, increased in germ-free male and no change in 
female mice (Diaz Heijtz et al. 2011; Neufeld et al. 2011); increased in germ-free female and 
no change in male mice (Luk et al. 2018). The inconsistency may arise due to differences in 
mouse strain (Elderman et al. 2018) and lab-to-lab variation in the gut microbiota composition 
in the SPF mice. Germ-free males have no effect or increased self-grooming, suggestive of 
repetitive behaviour but the females have not been analysed (Arentsen et al. 2015; Desbonnet 
et al. 2014). Male mice show increased sociability index (Arentsen et al. 2015) but conflicting 
study also reports reduced sociability with reduced social novelty score in males and no 
significant effect observed in female mice (Desbonnet et al. 2014). Germ-free male mice have 
reduced immobility time on forced-swim test, tail-suspension test (TST) as well as reduced 
latency to feed in novelty suppressed feeding task, suggestive of decreased depressive-like 
behaviour (De Palma et al. 2015; Luo et al. 2018; Zheng et al. 2016). While another report 
shows no effect on TST immobility or percent sucrose preference, the trend is towards a 
lowered depressive phenotype in germ-free male mice (Campos et al. 2016). We did not find 
many reports on anhedonia or depressive-like behaviour in germ-free female rodents, but there 
seems to be no effect on TST in female germ-free mice (De Palma et al. 2015). Germ-free 
female mice have impaired cognition and memory, with reduced c-Fos and BDNF protein 
expression in the hippocampus (Gareau et al. 2011). Similar to females, germ-free male mice 
also have lower hippocampal BDNF expression (Sudo et al. 2004) and reduced percent 
alteration rate on Y-maze suggestive of impaired working memory (Zheng et al. 2016). Though 
the germ-free studies report conflicting findings possibly due to differences in the control gut 
microbiome across facilities, sex difference is a common them across these studies.
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5.1.2 Antibiotic studies
The advantage of antibiotic treatment over germ-free studies is the temporal regulation of gut 
microbiota alterations or depletion, and translatability to humans. However, there may be 
differential findings based on the combination of antibiotics used, the dose and duration of the 
treatment as well as the route of administration and the age of the animals being tested. For this 
review, we will focus on behavioural sex-differences observed in control and antibiotic treated 
groups during specific life stage.
Preconception to gestation antibiotic treatment causes similar behavioural alteration in juvenile 
male and female offspring, with reduced social interaction and sensory-motor gating but no 
effect on anxiety-like or stereotypic behaviour (Degroote et al. 2016). Gestational antibiotic 
treatment reduces locomotor and rearing activity, and increases anxiety-like behaviour in the 
male offspring despite cross-fostering with control dams (Tochitani et al. 2016). Antibiotic 
administration to pregnant dams until weaning alters offspring behaviour in adolescence with 
reduced anxiety-like behaviour in males but not females (Leclercq et al. 2017). Male and 
female offspring of antibiotic-treated dams were comparable with unaltered locomotion and 
reduced sociability and social novelty, which were rescued by Lactobacillus administration to 
the dams (Leclercq et al. 2017). Postnatal oral gavage of antibiotics for 10 days increased 
visceral hypersensitivity only in adult male rats but did not alter anxiety-like behaviour or 
memory in males and female adult rats (O'Mahony et al. 2014). Chronic antibiotic 
administration post-weaning in male mice led to reduced anxiety-like behaviour, memory, and 
social interaction in adulthood, perturbed serum tryptophan metabolism, reduced hippocampal 
BDNF and Vasopressin levels (Desbonnet et al. 2015). Chronic antibiotic administration in 
late adolescence in male mice increased depressive-like behaviour, reduced social novelty 
without altering social interaction, nociception or working memory (Guida et al. 2018). These 
alterations were normalised and accompanied by increased alpha diversity of gut microbiota 
after suspension of antibiotics for around two weeks. 
Adult chronic antibiotic treatment given twice daily for 11 days altered novel object recognition 
memory but not spatial discrimination, anxiety-like or depressive behaviour in male mice 
(Frohlich et al. 2016). Chronic antibiotic treatment in adult females also reduce hippocampal 
neurogenesis and memory in NOR (Mohle et al. 2016). One week oral but not intra-peritoneal 
administration of antibiotics reduced anxiety-like behaviour in male mice, which were 
unaltered by vagotomy and accompanied with increased hippocampal and decreased 
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amygdalar BDNF protein levels (Bercik et al. 2011). Chronic 13-week antibiotic treatment in 
adult male rats increased visceral pain sensitivity, depressive-like behaviour, perturbed 
memory in Morris water maze task but not novel object discrimination task and did not alter 
anxiety-like behaviour or somatic pain sensitivity (Hoban et al. 2016b). Similar to rodent 
studies, antibiotic treatment in adult zebrafish reduced anxiety-like behaviour and social 
cohesion recapitulating an ASD-like state (X. Wang et al. 2016b). In case of Drosophila, diet-
induced mating preference was abolished with antibiotic treatment in both males and females, 
via altering the cuticular hydrocarbon sex pheromones (Sharon et al. 2010). 
In summary, depletion of gut microbiota using antibiotics seems to have no effect or a 
detrimental effect on emotional and cognitive behaviour with the exception of reduced anxiety. 
Taken together, these data suggest that: a) antibiotic treatment in different windows of life 
differentially modulate behaviour, possibly by altering the gut microbiota, with specific sex 
differences, b) male and female brain develop and mature differently, gut microbiota 
perturbation at specific ages might end up affecting different circuits and thereby behaviour. 
While this concept of critical windows is not new, research is warranted to explore sex 
differences in microbiota-brain connection throughout development.
5.1.3 Probiotics, Prebiotics, and Diet
Meta-analysis of probiotic studies suggests a mood enhancing effect of probiotics in animal 
models but mixed findings for clinical studies (R. T. Liu et al. 2019b; Reis et al. 2018). In the 
past decade, probiotics including Lactobacillus and Bifidobacterium species have been 
assessed as a therapy for mental disorders such as ASD, anxiety, MDD, and to a lesser extent 
for schizophrenia, multiple sclerosis, Alzheimer’s and Parkinson’s disease. Prebiotic and 
probiotic treatment is effective in autism (Grimaldi et al. 2018) and has mood enhancing effects 
on patients with anxiety and depression (C. S. Kim and Shin 2019; R. T. Liu et al. 2019b; J. 
Liu et al. 2019a). However, other reports showed no effect, which may be due to dose and 
combination of probiotics used, study design and duration of treatment (Kelly et al. 2017b; Ng 
et al. 2018; Romijn et al. 2017). Prebiotic as well as faecal microbiota transfers in autism have 
beneficial effects on behaviour and gastrointestinal function of the patients (Kang et al. 2017). 
There is an increased interest in assessing clinical benefits of diet, prebiotic and probiotic 
treatments on other mental disorders. 
Probiotic treatment for schizophrenia did not improve positive or negative symptoms but 
reduced the occurrence of bowel problems during the treatment phase (Dickerson et al. 2014). 
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Another study using fermented milk reported reduced constipation in patients with Parkinson’s 
disease without altering dopaminergic therapy requirements, but motor function and sex 
differences were not evaluated (Barichella et al. 2016). However, increased dietary intake of 
polyunsaturated fats is inversely associated with Parkinson’s disease, but an alteration in the 
gut microbiota has not been characterized (Kamel et al. 2014). Lactobacillus rhamnosus 
HN001 reduced anxiety and depression in postpartum depression (Slykerman et al. 2017b). 
Probiotic Bifidobacterium longum NCC3001 reduced depression symptoms in IBS patients 
(Pinto-Sanchez et al. 2017). Current research involving adjunct therapy consisting of probiotics 
with dietary components in treatment of brain disorders shows promising results (Burokas et 
al. 2017; Jamilian et al. 2018; Miyaoka et al. 2018; Ostadmohammadi et al. 2019; Raygan et 
al. 2018).
In animal model of ASD, maternal immune activation causes behavioural deficit, increase: gut 
permeability, relative abundance of Clostridia and Bacteroidia, and serum 4-
ethylphenylsulfate, which were all rescued by Bacteroides fragilis treatment (Hsiao et al. 
2013). In three different mouse models of autism (genetic, environmental, and idiopathic 
models), L. reuteri treatment alone reversed social deficits in males (Sgritta et al. 2019). This 
effect was modulated via the vagus nerve and oxytocin. Oxytocin levels are reduced in social 
disorder observed in rodent studies, and administration of L. reuteri seems to reduce social 
deficits and upregulate oxytocin levels in the PVN of the brain (Sgritta et al. 2019). Further L. 
reuteri also possess beta glucuronidase property that may enhance unconjugated oestrogen 
levels, which is known to regulate oxytocin levels (Acevedo-Rodriguez et al. 2015; Varian et 
al. 2017). It would have been interesting to see the effects in females since stress leads to greater 
colonic stress response with increased inflammation in females, an effect rescued by probiotic 
Lactobacillus farciminis (J. Y. Lee et al. 2017b). 
Several preclinical and clinical studies associated with pre-/probiotic administration and FMT 
raise concerns about the ideal healthy host gut microbiota composition and ratios of key 
microbial species (Jayasinghe et al. 2016; Konig et al. 2017; Larsen et al. 2019; Suez et al. 
2019). Thus, it is important to assess the gut microbiota composition prior to treatment and also 
determine the appropriate doses and combination of gut microbiota for an efficacious effect. 
Apart from bacteria, use of bacteriophage may also be considered to eliminate harmful gut 
microbiota species (Shkoporov et al. 2018; Sulakvelidze et al. 2001). This is a very nascent 
field and a lot of on-going work is addressing the co-influence of phage composition and mental 
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disorders (Bedarf et al. 2017; Severance et al. 2016). Further interrogation can delineate the 
role of sex hormones in behavioural and physiological outputs.
5.1.4 Other studies
Common food additives such as emulsifiers when administered orally to mice post-weaning, 
increased anxiety in males and reduced social novelty preference in females (Holder et al. 
2019). The group had previously shown emulsifiers potentiate inflammation and directly alter 
gut microbiota composition using an ex vivo model of mucosal simulator of the human 
intestinal microbial ecosystem (Chassaing et al. 2017).
5.2 Inflammation, Metabolism and Neurotransmitters
Many brain disorders are stress- or inflammation-related disorders, which poises them to be 
modulated by the microbiota (C. R. Martin et al. 2018; Scott et al. 2017). Both the stress and 
immune responses are critical innate systems of healthy ageing and normal development, but 
dysfunctions can predispose individuals to a more vulnerable state leaving them more 
susceptible to mental disorders (Codagnone et al. 2019). Recent evidence implicates a role for 
the microbiota at the interface of the stress and immune system, which regulate host physiology 
to mediate effects in the brain (Foster et al. 2017; Rea et al. 2016; Thion et al. 2018a). As well 
as the role of the gastrointestinal microbiota in maintaining a healthy resting inflammatory tone 
at the level of the gut, the involvement of microbial-derived metabolites including 
neurotransmitters, neuropeptides and SCFAs in regulating the systemic immune and stress 
response has been reviewed extensively (Bruce-Keller et al. 2018; Morris et al. 2017; Russo et 
al. 2018). 
Animal studies involving germ-free and other models, suggest sex-differences in the immune 
system (Fransen et al. 2017; Thion et al. 2018b) and metabolism (Baars et al. 2018; Clarke et 
al. 2013; H. Gao et al. 2019a; Kaliannan et al. 2018), which may play a role in determining 
which specific microorganisms are best suited to colonising the gut, which in turn may 
modulate overall physiology and behavioural outcome (Table 4). For example, GF females 
have increased intestinal type 1 interferon signalling compared to GF males that may colonize 
sex-specific microbiome (Fransen et al. 2017). Microglia are the predominant immune cells in 
the CNS and play an essential role in directing key processes including neurodevelopment, 
neurogenesis, synaptic pruning, and neuroinflammation (Jacobs et al. 2019; Tremblay et al. 
2011). Germ-free mice show increased microglial density and excess ramification compared 
to SPF mice across different brain regions during development (Thion et al. 2018b). However, 
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one-week antibiotic treatment in adults had no effect on the density and morphology of 
microglia in either of the sexes (Thion et al. 2018b). Sex- and age-specific effects were also 
observed in the somatosensory cortex of GF mice compared to SPF mice, with greatly 
perturbed microglial density and transcription profile in male fetuses and adult females (Thion 
et al. 2018b). Trancriptomic analysis identified that in males the key signaling pathways 
involved were linked to the immune response whereas in females they were linked to 
transcriptional regulation. These microbiota-induced alterations may involve sex hormone 
regulations considering that the female sex hormone, oestrogen has a pro-inflammatory and 
male sex hormone testosterone has an anti-inflammatory effect (Klein and Flanagan 2016). 
The GF male but not the GF female mice have elevated levels of hippocampal serotonin and 
its major metabolite, as well as circulating serum tryptophan levels compared to conventional 
sex-matched mice (Clarke et al. 2013). Restoring the gut microbiota in post-weaned GF male 
mice reversed reduced anxiety levels and peripheral tryptophan levels, but hippocampal 
serotonin levels were not affected (Clarke et al. 2013). These sex-specific microbiome profiles 
in turn may facilitate sex differences in physiology and behaviour. This idea is supported by 
the study where absence of gut microbiota diminished sex specific liver gene expression as 
well as lipid metabolic profile (Weger et al. 2019). Exposure to manganese in mice, which may 
occur through diet or environment, show sex differences in microbiome composition, amino 
acid metabolism, and reduced GABA-synthesizing enzyme expression only in males (Chi et 
al. 2017). It is unclear what role other macro and micronutrients may play in this context and 
whether their effects are sex dependent. Lactobacillus also regulates central GABA receptor 
expression via the vagus nerve in males (Bravo et al. 2011). This could change the levels of 
neurotransmitters and downstream signalling in specific brain regions, which also show sex-
differences, thereby causing differential emotional responses. Sexual dimorphism is also 
reported for the neuropeptide Arginine Vasopressin (AVP), released from the hypothalamus, 
with increased expression in normal males (Fields et al. 2018). AVP regulates stress response 
and affect social and anxiety-like behaviour. Antibiotic administration decreases hypothalamic 
AVP expression, and AVP gene knockout and knockdown data suggests AVP influences gut 
microbiota composition in gene dose-dependent and sex-specific manner (Fields et al. 2018). 
Sex-differences have also been reported in the colonization of germ-free mice using human 
male microbiota, where female mice show greater diversity while male mice microbiota 
resembles more closely with the donor (J. J. Wang et al. 2016a). The study also reports specific 
sex-differences in OTUs and their interaction. Caesarean section mode of delivery in mice has 
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greater impact on adult female gut microbiome and body weight gain compared to males 
(Martinez et al. 2017). Collectively, these studies suggest important contribution of gut 
microbiota in sex-dependent metabolic effects, which may in turn regulate behavioural 
outcome.
5.3 Sex Hormone function
Metagenomic studies suggest that gut microbiota are capable of synthesizing steroids, 
modifying oestrogen, and expressing hydroxy-steroid dehydrogenases, enzymes responsible 
for regulating a balance between the active and inactive steroids (Wallis et al. 2016; Zou et al. 
2019). The terms ‘sterobiome’ and ‘estrobolome’ have been used to represent the combination 
of enteric bacterial genes that can metabolize steroid or oestrogen respectively (Baker et al. 
2017; Ridlon and Bajaj 2015). The gut microbiota in principle may regulate hormonal and 
steroidal levels that have a plethora of physiological effects due to widespread expression of 
oestrogen and androgen receptors. While oral contraceptives increase the gut permeability and 
risk of intestinal bowel disease, antibiotic treatment in turn is also speculated to affect oral 
contraceptive efficacy but thorough clinical research in these observations are lacking (Khalili 
2016; Simmons et al. 2018). 
In animal studies, female mice are reported to have lower serum 17-betaoestradiol levels post 
antibiotic treatment (Kaliannan et al. 2018). Similarly, in germ-free mice, females have reduced 
levels of oestradiol, progesterone and corticosterone (Kamimura et al. 2019), while males have 
higher oestradiol levels compared to SPF mice (Kubeck et al. 2016). In comparison, adult 
germ-free mice, serum testosterone levels were higher in females while lower in males 
compared to sex-matched SPF mice (Markle et al. 2013). Further, transfer of SPF adult male 
caecal content to pubertal female mice was sufficient to increase serum testosterone levels, and 
to masculinize microbiota composition, and alter the metabolic signature in adult female mice 
(Markle et al. 2013). These effects were blocked by an androgen receptor antagonist, flutamide 
suggesting an important role for testosterone signalling in mediating the consequences on male 
caecal microbiota transfer in females. The opposite study of transfer of adult female caecal 
content into pubertal males has not been done but considering no difference in pre-pubertal 
male or adult female caecal content, it may not have any drastic effect on gut microbiota 
composition. Interestingly, smaller litter size and problems in generating colonies are 
commonly reported in germ-free maintenance colonies, along with reduced progesterone levels 
during the start of dioestrus (Shimizu et al. 1998). Faecal microbiota transfer from 
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conventionalised animals attenuates these abnormalities. In humans, oestrogen levels correlate 
with faecal microbiome abundance and alpha diversity in the postmenopausal women (Vieira 
et al. 2017). However, an in-depth impact of human gut microbiota in sex hormonal signalling 
and fertility is a topic for future research. Oestrogen is inactive in the conjugated form, and 
beta-glucuronidase producing gut microbiota can convert the conjugated form to an 
unconjugated form, which is free to bind to the oestrogen receptor (Flores et al. 2012). 
Oestrogen have a plethora of physiological consequences throughout the body including 
several brain regions (McCarthy and Arnold 2011). Prolonged conjugated oestrogen 
supplementation causes reduction in gut microbiota beta-glucuronidase activity without 
modulating the gut composition (K. L. A. Chen et al. 2018b). Further androgens are converted 
to oestrogens via the aromatase enzyme, expressed locally in neurons and brain cells (Callard et 
al. 1980), thus developmental regulation of aromatase activity in males and females can also 
impact synaptic plasticity and neuronal circuit dynamics (Bender et al. 2017; Lu et al. 2019). 
It is thus interesting to ask whether aromatase activity may also be modulated by the gut 
microbiota.
5.4 Bile Acids and Dietary Hormone-Mimetic
Gut commensals are exposed to harsh environments, especially with presence of bile acids 
(BA) that possess bactericidal properties by destroying the bacterial lipid cell wall. The gut 
commensals have in-built resistance mechanisms such as expression of enzymes and efflux 
pumps capable of modifying steroids or releasing them out of the cells. Bioinformatics and 
microbiological analyses have determined several bacterial enzymes capable of modifying 
steroids including oestrogens and BA (Zou et al. 2019). Ketosteroid reductases, an 
oxidoreductase expressed by Actinobacteria, Proteobacteria, and Firmicutes, reversibly 
convert testosterone to androstenedione, and oestradiol to oestrone among other ketosteroids. 
Some of the enzymes within this group (enzyme required for 21-dehydroxylation) are 
exclusively expressed by the gut commensals (Ridlon and Bajaj 2015). In addition, pathogenic 
bacterial species belonging to Streptococcus and Bacillus genus express 5α-reductases, several 
other ketosteroid reductases that can act on BA and sex hormones. Bacteria such as E. coli and 
Campylobacter jejuni possess multidrug efflux pumps responsible for releasing BA from the 
bacterial cells (Garcia-Gomez et al. 2013; Lin et al. 2003). Antibiotic exposure in mice 
perturbed 87% of detected intestinal metabolites, with maximum change observed in steroid 
metabolism including BA and sex hormones (Baars et al. 2018). The authors also report the 
emergence of sex-specific BA composition in conventionalised male and female mice 
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compared to germ-free mice, with higher BA levels in females and more complex BA in 
conventionalised females (Baars et al. 2018). Germ-free mice have increased gall bladder size, 
increased density of BA transporters, higher BA concentration in serum, liver, and ileum 
(Selwyn et al. 2015). Moreover, BAs have been implicated as regulators of the gut brain axis 
in a mouse model of autism (Golubeva et al. 2017). BA acts as emulsifiers facilitating 
absorption of fats including short chain fatty acids (SCFA). Control female mice have higher 
SCFA-producing bacteria along with increased SCFA in colonic tissue compared to males (H. 
Gao et al. 2019a). Specific antibiotics have sex dependent effects on SCFA-producing bacteria, 
BA and SCFA levels (H. Gao et al. 2019a), which can regulate behavioural responses possibly 
via SCFA receptors or epigenetic modifications by butyrate (van de Wouw et al. 2018). Higher 
levels of SCFA and BA may give an advantage to females against brain disorders, but whether 
fluctuating hormonal levels modulate SCFAs thereby playing a detrimental role is unclear. 
Environmental and dietary sources of oestrogens and steroid mimetics can have detrimental 
effects on the body. The gut commensals may interact with these factors thereby influencing 
the exogenous steroid metabolism and levels. One such example is the plant-derived 
phytoestrogens, such as lignans, isoflavones, and coumestans, which are structurally and 
functionally similar to oestrogens with higher affinity for ERβ, oestrogen receptor with 
anxiolytic property (Oyola et al. 2012; Patisaul and Jefferson 2010). Several studies have 
addressed the influence of phytoestrogens on neuropsychiatric symptoms especially during 
menopause [Reviewed in (Fattah 2017)]. Phytoestrogens modulate cognition in humans (Zhao 
and Brinton 2007). In animals, sex-distinct effects of phytoestrogens on anxiety and spatial 
memory are reported, where it decreases anxiety and enhances spatial memory in females, with 
opposite effects in males (Lund et al. 2001; Patisaul et al. 2005). The beneficial and detrimental 
effect of phytoestrogens is an active area of research with a potential to generate efficacious 
therapeutic interventions for physiological and neuropsychiatric disorders (Patisaul and 
Jefferson 2010; Rietjens et al. 2017). 
6 Summary & Conclusion
Taking all together, the following picture emerges when one is considering the impact of sex 
on the microbiome-gut brain axis: 1) The male brain is particularly vulnerable to microbiota-
based insults in early life. 2) Animal studies in a controlled environment show greater sex 
differences in microbiome-gut-brain axis than human studies where large cohorts are generally 
needed to unmask sex differences. 3) Absence of gut microbiota seems to diminish inherent 
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sex difference on a variety of physiological measures. 4) The microbiome alone or by 
modulating sex hormones can drive inflammatory and metabolic factors including SCFAs and 
neurotransmitters, thereby increasing sex differences. 5) The microbiome-regulated sex 
hormones along with the immune and metabolic factors can alter brain cells (microglia, 
oligodendrocyte, and neurons) modifying neuronal circuitry thereby impacting behavioural 
changes. 6) Male gut may also have an increased inflammatory tone affecting the microbial 
colonization early in life. 7) Compared to higher sex hormone drive in males during 
development, female ovaries do not secrete oestrogen, and this may underpin the fact that 
females are more frequently colonized by Lactobacillus and Bifidobacterium at birth, which 
may be beneficial to the developing brain. 8) In adolescence with the rise of sex hormones, 
males have a reduced testosterone-mediated inflammatory tone, and this may lead to 
divergence of gut microbiome profile as seen in case of Prevotella (more), and Akkermansia 
(less). 9) Diet-induced changes in the microbiome can aggravate oestrogens-induced 
modulation of synaptic plasticity, stress axis and behaviour. 10) Dietary components as well as 
drugs and dietary sex hormone mimetics can sex-dependently alter the microbiome, and thus 
modulate a cascade of physiological events leading to behavioural changes. 11) Further studies 
are critically needed in both animals and human cohorts to understand the relative bidirectional 
contribution and dynamics of sex hormones to microbiome-induced effects. Likewise, there is 
a pressing need to understand the sex-dependent compensatory changes with diet, drugs, 
probiotics, and other factors at the level of microbiome and host. 
Host genetic microbiome interactions are also being characterised with the possibility of 
heritable microbiome (Goodrich et al. 2014; Goodrich et al. 2017; Zhernakova et al. 2016) and 
it would be interesting to check for sex difference in the context of brain health (Corella et al. 
2018). Because of genetic- and environmental- differences in the microbiome composition, it 
is clear that the microbiome field is at the heart of precision medicine (Kashyap et al. 2017; 
Zmora et al. 2018) and precision nutrition approaches (Bashiardes et al. 2018; Mills et al. 2019; 
Zeevi et al. 2015). Whether different tailored microbiome-based interventions should be 
generated across both sexes warrants much further exploration.
To conclude, it is clear that although there is enough evidence to suggest an interaction between 
the sex, sex hormones and the gut microbiome on brain and behavioural outcomes much 
research is still needed to unravel its contribution. Given the sex bias that exists for the 
prevalence of mental disorders (Fig. 1), further studies into the interaction of sex hormones and 
gastrointestinal microbiota on the onset, prevalence and progression of these debilitating 
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neurological disorders are warranted. It cannot be stressed enough that many mental disorders 
are often associated with metabolic or immunological problems; and while the early life 
environmental factors and genetics including sex, play a huge role, the focus needs to shift on 
perturbing the most amenable factor, the gut microbiota, for a potential sex-dependent therapy.
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Figure 1. Sex-bias in several brain disorders and their likely onset. The disorders shown 
on left show higher prevalence in males, and the ones on right show greater prevalence in 
females (males-green, females- purple). Vast majority of gut bacteria are equipresent in males 
and females, while some bacterial taxa show sex-difference in abundance, irrespective of health 
status. Male to female ratio and data source for mental disorders: ASD (3:1)- (Loomes et al. 
2017), ADHD (4:1)- (Erskine et al. 2013), Schizophrenia (1.7:1)- (Jongsma et al. 2019), 
Parkinson’s disease (1.48:1)- (Picillo et al. 2017), generalized anxiety (1:1.9)- (Remes et al. 
2016), MDD (1:1.95)- (Salk et al. 2017), Anorexia nervosa (1:10, high variation 1:3 to 1:12)- 
(Raevuori et al. 2014), PTSD (1:2)- (Galea et al. 2005), Alzheimer’s disease (1:1.18)- (G. B. 
D. D. Collaborators 2019a), MS (1:2)- (G. B. D. M. S. Collaborators 2019b).
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Figure 2. An overview of sex differences in sex hormonal levels, gut microbiome profiles 
and neurological readouts across lifespan. Gestation- oestrogen levels are comparable 
between males and females, while testosterone levels increase in male foetus with development 
of the gonads. At this stage, the foetal microbiome is largely non-existent, but the maternal gut 
microbial metabolites may influence foetal development. This is a critical stage as the brain is 
still developing and maternal stress, inflammation, hormones and oher microbial factors may 
influence neuronal circuits and impact behaviour. After birth, there is a surge of sex hormones 
observed, which is thought to play a role in sexual differentiation of brain and behaviour. While 
most studies on infants do not report sex- differences in alpha diversity, one study does point 
to a greater alpha diversity in males along with increased extraversion, while female infants 
display greater inhibitory control. Genera that metabolize milk oligosaccharides, Lactobacillus 
and Bifidobacterium are better colonized in female gut in infancy, this could improve gut 
barrier and enhance nutrient availability, bile acids and short chain fatty acids, protecting the 
females against earlier environmental insults. Most studies at prepubertal stage, characterized 
by minimum levels of sex hormones, do not report sex differences in alpha diversity. Puberty 
arises earlier in females along with emergence of sex-specific sexual and emotional behaviours.  
In adulthood, males have a steady testosterone level, which gradually declines with age, while 
females show a cyclical pattern of hormones through menstruation with menopause leading to 
a sharp decline in oestrogen levels. The alpha diversity of gut microbiome is higher in 
reproductive females with no difference observed in middle-age adults. Adult females seem to 
have higher Firmicutes/Bacteroidetes ratio along with other differences in microbiome taxa. It 
41
is unclear if sex differences exist in ageing population, but higher alpha diversity seems to be 
a hallmark for healthy ageing. In adults, neuroimaging and biochemical studies in humans and 
animals report anatomical and neurochemical (monoamine pathways) differences in the brain 
such as: increased white matter in males and grey matter in females, increased volume of 
preoptic area and bed nucleus of stria terminalis (BNST) in males, while larger Anteroventral 
Periventricular nucleus of hypothalamus (AVPV) in females. These regions are responsible for 
sexual behaviours and are modulated by sex hormones. While several sex differences exist in 
the brain, there is a large overlap and brain cannot be categorized as masculine or feminine but 
consists of mosaics.
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Table 1. Sex differences in gut microbiota composition in healthy humans across lifespan.
Age Cohort/Strain Males (M) Females (F) Reference
Birth- 3 
months Antwerp, Belgium  








↑Bifidobacterium until 11 
weeks. No effect of Vit. A.
(Huda et al. 
2019)
2.5 month
FinnBrain Birth Cohort 
Study, Finland, 
temperament at 6 months






US ethnically diverse 
VDAART study (Vitamin 












Columbus, Ohio, US 








Community type D: 
↑Prevotella 
↓Bacteroides
Community type C: 
↑Ruminococcaceae, 
Alistipes, Faecalibacterium 





American gut project- 
citizen science initiative- 
US and UK cohort
α-diversity: F>M, less pronounced in middle age. 
Sequence variant (SV) richness: 
US- M=F, UK young adult cohort- F>M












years Dutch, LifeLines-DEEP 
12 microbial species 













Spanish, COR- DIOPREV 
study (CORonary Diet 












Control from colorectal 
cancer study, Washington 
D.C., US
 ↑Bacteroidetes Obese F-↓Bacteroidetes
(Dominian

















Spanish ONCOVER study 
(volatile compounds 
detection system for the 
early cancer diagnosis)
↓Actinobacteria 
















Spanish, COR- DIOPREV 
study BMI>33 -↓Bacteroides 
compared to BMI<33 No difference
(Haro et al. 
2016) 
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Table 2. Sex influences gut microbiome in male and female rodents. (Bolded words indicate congruous findings across two or more studies.)




P2 None ↑Haemophilus, ↑Sphingobium ↑Streptococcus (Jasarevic et al. 2017)
 Mouse 
NOD/Jsd 3 weeks None No sex difference in gut microbiota.
(Markle et al. 
2013)
Mouse C57BL6/J 












NOD/ShiLtJ 4 weeks None No sex difference in gut microbiota.
(Yurkovetski
y et al. 2013)
 Mouse 
NOD/Jsd 6 weeks None Sex difference in gut microbiota.
(Markle et al. 
2013)
Mouse 
C57BL6/J 6 weeks None
















↑Shannon α-diversity, Microbiome: 




months None ↑Roseburia, Bilophila, Coprococcus I.
↑Parabacteroides, Incertae sedis 
(Lachnospiraceae).






↑Shannon α-diversity, Dehalobacterium, 
AF12, Bacteroides, Dorea, Mucispirillum, 
Roseburia, Adlercreutzia, Ruminococcus, 
Anaerostipes. 
Colonic content: ↑Pheylalanine and Tyrosine.
↑Lactobacillus, Prevotella, Sutterella.
Colon: ↑SCFA.
(H. Gao et al. 
2019a)
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↑Shannon α-diversity, Bacteroides, Alistipes, 
Clostridiales, Ruminococcus, and 
Rikenellaceae.
↑Firmicutes, 
↑Firmicutes/Bacteroidetes ratio, and 
Lactobacillus.




















↑Actinobacteria and Tenericutes phyla, genera- 
Allobaculum, Anaeroplasma, and Erwinia.
↑SMB53 (Colstridiaceae) and 3 
members of family Lachnospiraceae 
(Dorea, Coprococcus and 
Ruminococcus)







with SPF F at 
birth
↑Cytophagaceaee and Bacteroidaceae 
(Bacteroidetes), ↑Peptostreptococcaceae 
(Firmicutes).
Sex-difference in microbiome 
clustering. 
(Yurkovetski








↑Roseburia, Blautia, Coprococcus I, 
↓Peptococcus compared to SPF F (not 
at 34 weeks). 
Microbiome distinct from SPF M & F.









1:50 in drinking 
H2O.








GDX+ High fat- 
high sucrose diet 
(HFD)
 GDX + chow diet: Altered microbiome,
reversed by testosterone except for DBA2J.
 GDX + HFD: ↑Ruminococcaceae
 GDX + HFD: Altered microbiome
↓Akkermansia






♂ Castration at 4 
weeks
 Gut microbiome clusters overlap with F.
 ↓Lactobacillaceae compared to M, and =F.
(Yurkovetski







 Gut microbiome composition = M.










11-17 week: E2 
(oestradiol)
 E2: ↓Proteobacteria, gut microbiome closer 
to F and distinct from M/OVX.  
 M+E2: ↑Akkermansia.
 OVX+E2: ↑B/E ratio, ↑Bilophila, 
Alistipes, Bacteroides and 










reuteri at 10 w.
 OVX+P4: ↑Lactobacillus, ↓anxiety on OFT not EPM, ↓immobility on FST compared 
to OVX. Blocked by ABX. 
 OVX+P4/ L. reuteri: ↑hippocampus BDNF and ↓immobility on FST. 
 P4: ↑Lactobacillus reuteri growth in vitro.






s.c. E2- 1 week 
prior to myelin 
protein 
immunization. 
 E2 protect against autoimmune Encephalomyelitis (EAE) in animal model.
 ↑diversity, Lactobacillaceae, Coriobacteriaceae and unidentified family from the 
Bacillales order.













 ↓ Lactobacillus, Ruminococcus and Clostridium, ↑Prevotella. 
 ↑Androgens, ↓Oestrogens, perturbed oestrus cycle. 
 Rescued by 2-week Lactobacillus reuteri or FMT from healthy F.









 ↓Akkermansia, Bacteroides, Lactobacillus, Clostridium.
 ↓Leutinizing hormone, ↑body weight, hypertension, adipokines mRNA in white 
adipose tissue. 
 ↑bacteria associated with steroid hormone synthesis (Nocardiaceae and 




Table 3. Summary of human studies reporting sex differences associated with gut microbiome in behaviour and mental health.





16S Illumina MiSeq. 
2.5-month stool sample. 
6-month Infant Behaviour 
Questionnaire.
 Bifidobacterium associated with 
surgency.
 ↑Bifidobacterium and 
Clostridiaceae, ↓Veillonella- 
↑regulation.
 ↑Veillonella- ↓fear reactivity. (Aatsinki et al. 2019)
Columbus, Ohio, U.S. 18-27 months




 ↑ Motor activation, high intensity 
pleasure, extraversion. 
 ↑ Phylogenetic diversity and 
Shannon index- ↑sociability and 
high intensity pleasure. 
 ↑Ruminococcaceae genus and 
Parabacteroides– ↑sociability.
 ↑Rikenellaceae genus and Dialister- 
↑high intensity pleasure. 
 Ruminococcaceae ↑with age.
 ↑ Inhibitory control, soothability, 
and effortful control. 
 ↑ Shannon index- ↓effortful 
control. 
 ↑Rikenellaceae genus- ↑fear. 











(immune system) gut 
microbiota associated 
epitope (ME).
 ME diversity 
 ASD > non-ASD.
 ME diversity 
 ASD = non-ASD.
(Wang et 
al. 2019)
ChiBS study, Belgium 8-16 years
16S Illumina Miseq. 
Coddington Life Events 
Scale for Children, self-test 
for emotion.
 No sex difference in gut microbiota 




Health Study, Korean, 
Cross-sectional study 




16S Illumina MiSeq. 







Gammaproteobacteria but not 
significant post FDR correction.
(Kim et al. 
2018)
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16S Illumina MiSeq. 
Bipolar disorder patient 
(BD), Healthy relatives and 
individuals. 
 Flavonifractor associated with 
BD F>M. (Flavonifractor-may 




Illinois, U.S. 25-45 years
16S Illumina MiSeq2000. 
Depression, anxiety, and 
stress scales-42 (DASS).
↑ DASS scores:
 ↑Butyricimonas, and 
Phascolarctobacterium,
 ↓Dorea, Rikenellaceae, 
Ruminococcus, and Blautia.
↑ DASS scores:
 ↑ Lactobacillaceae, Lactobacillus, 
Dialister, Paraprevotella, 
Bacteroides, and Bacteroidaceae,




First episode drug 
naïve MDD and 










 ↑21 OTUs and ↓53 OTUs.
 ↑ Atopobium, Bacteroides, 
Veillonella, Erysipelotrichaceae 
incertae sedis, and and 
↓Anaerovorax, Gordonibacter, and 
Pyramidobacter. 




 ↑29 OTUs and ↓28 OTUs. 




 ↓Howardella, Sutterella, and 
Pyramidobacter. 
 ↑HDRS score- ↓Clostridium XIVa, 
Erysipelotrichaceae incertae sedis, 
and Streptococcus.
(Chen et al. 
2018)






16S Roche 454 FLX 
pyrosequencing. Diffusion 
tensor imaging of brain 
white and grey matter. Trail 
making test for cognition.
 Obesity: ↓ Bacterial diversity.
 Obesity: X Bacterial diversity.
 ↑Age, intra-abdominal fat- 
↓Actinobacteria.
(Fernandez-








Bacterial culture and 
MALDI-TOF MS analysis. 
Cross-sectional. Bioscreen 
Patient Questionnaire
 ↑ME/CF symptom-↑Streptococcus 
and Lactobacillus. 
 (Possible detrimental effect of ↑ D-
lactate).
 ME/CF- ↑ behavioural 
impairment.






Table 4. Summary of animal studies reporting sex differences associated with microbiota-gut-brain axis.
Species, strain Age Method Sex-Specific Effects in Males (M) Sex-Specific Effects in Females (F) Ref.








GD1-7: chronic variable stress.  
Offspring microbiome.
16S Illumina Miseq.
 P28: ↓β-diversity and Flexispira, 
↑Desulfovibrio, Dehalobacterium, 
Clostridiales, Lachnospiraceae
 P28: No change
 Stress abolished sex difference in 
microbiota composition
(Jasarevi







Alternate day restraint and FST for 
19 days at 6 weeks.
16S Illumina Miseq.
 OFT: No effect on rearing
 EPM: ↑ total distance (M>F)
 ↓Ruminococcus gnavus
 OFT: ↑ rearing in centre
 ↑Ruminococcus gnavus, ↓Sarcina
(Tsilimig












 ↓ Pup USV




 X EPM, Marbles buried
 USV: mild impairment
 X social interaction.
 ↑ EPM anxiety COR ↓Clostridium 
XIVa, ↓Lachnospiraceae






Sprague Dawley 6 weeks
MIA + ABX
P3, P5: LPS i.p. 
P35- P39: ABX once daily oral 
gavage. (Neomycin, polymyxin B 
and metronidazole).
16S Illumina HiSeq 2500.
 ↓ Social preference towards LPS-
treated rats (partially rescued with 
ABX)
 LPS: ↑Hypothalamus oxytocin 
receptor gene expression
 LPS /ABX: No sex difference in 
microbiome
 LPS: X PFC/Hypothalamus 







GD12-16: s.c. daily propionate or 
GD15-16: s.c. daily LPS. 
P10-18: Twice on alternate days 
s.c. propionate.
 LPS: ↑acoustic startle
 Prenatal propionate: ↓prepulse 
inhibition.
 Prenatal +Postnatal propionate: 










GD30: PolyI:C. Offspring 
microbiome and behaviour.
16S Illumina MiSeq. 
 ↑ Adult amphetamine-induced 
locomotion
 ↓ Social preference
 Larger alteration in β-diversity







GF/ Con / Bifidobacterium
P1: gavage GF dam +SPF bedding. 
GF postnatal colonization with 
Bifidobacterium (human infant 
type). 16S Illumina MiSeq.
 GF: X EPM, OFT,
↓ motor performance (rescued by 
Bifid.)
 Bifid: ↑EPM anxiety, X OFT
 GF: ↓ EPM, OFT anxiety (rescued 
by Bifid), 











1 week enrofloxacin (Microbiome), 
1 week enro, 1 week break, 1 week 
enro, 1 week post treatment monitor 
(Behaviour), 16S Illumina MiSeq
 ↓Cyanobacteria, Proteobacteria, 
Elusimicrobia, and Euryarchaeota
 ↑TM7
 ↓Aggression on 2nd treatment
 ↓Cyanobacteria, Proteobacteria, 
and Tenericutes







13-week diazinon in drinking water 
(agriorganophosphate insecticide). 
Faecal metabolomics, Illumina- 16S 
MiSeq, shotgun NextSeq.
 Gut microbiome:
↑9 genera, ↓10 genera 
Altered Bacteroides, Coprobacillus, 
Butyrivibrio, Staphylococcus, 
Lachnospiraceae_Johnsonella
 Altered bacterial genes: potassium 
and neurotransmitter metabolism, 
chemotaxis
 ↓faecal taurine and glycine M>F
 Gut microbiome: 




 Altered bacterial genes: 









Exercise + Diet Preference
P49- 1-week voluntary wheel 
running (run)/ sedentary (sed). 




 ↓ Body weight 
 ↓ High-fat preference
 ↑ High sucrose and corn-starch 
preference  
 ↑ Chao1 diversity
 Microbiome altered
 Run distance F>M
 X Body weight, dietary preference
 ↑ Calorie intake
 Microbiome unaltered
 ventral striatum: ↑preproenkephalin 
and μ-opioid receptor 1 mRNA
(Lee et 
al. 2017)







GD1-7: Chronic variable stress, 
vaginal proteomics. Pup colon and 
plasma metabolomics. Brain amino 
acids. 16S Illumina MiSeq.
 ↑Bacteroides and Clostridium 
compared to control, similar to 
control ♀ pup
 PVN: ↓free amino acid levels
 ↑Bifidobacterium, similar to control 
♂ pup
 PVN: ↑or no change in free amino 
acid levels
(Jasarevi










Prenatal stress + Vaginal 
microibota transfer
C-section offspring from control or 
stress dam colonized with control 
(C) or stress (S) vaginal microbiota 
at birth. 16S Illumina MiSeq. 
Shotgun Illumina NextSeq500.
 Colonization with stressed 
microbiome:
↓ Body weight (not at P70)
↑ Stress-induced corticosterone
 EPS: ↑gut inflammatory signatures 
at E18.5
 E18.5 controls: ↑ gut inflammatory 
monocytes and neutrophils
 EPS: ↓ sex-differences in several 
parameters
(Jasarevi







MIA + MS + Maternal CUS
GD17: LPS, 
P2-P14: daily MS+CUS. 
Medial PFC RNA microarray.
5-month: faecal sample.
16S Illumina MiSeq.
 X stress-induced corticosterone
 2.5 months- ↑paracellular 
permeability (not at 5.5 months)
 ↑33 ↓59 OTUs, ↑Lactobacillus, 
Bacteroides, Alloprevotella
 mPFC: ↑18 ↓138 genes
 ↑ Social behaviour COR ↑Arc
 Impaired stress-induced 
corticosterone recovery
 Visceral hyposensitivity, and no 
effect on intestinal permeability
 ↑27 ↓37 OTUs, ↓Lactobacillus and 
Mucispirillum
 mPFC: ↑91 ↓17 genes










5-7 week: Kefir (probiotic), 
at 6 week- single LPS injection.
LPS only: ↑Proteobacteria
Kefir + LPS: 
 ↓Proteobacteria and LPS sickness 
score
 X body weight
 Serum: slight ↓ IL levels
 Brain: ↓ IL-6 mRNA
LPS only: ↓Firmicutes ↑Bacteroidetes
Kefir + LPS: 
 Faster improvement in LPS sickness 
score.








Chronic stress + PUFA
28 days social isolation, dietary 




 ↑Allobaculum, RF39, Lactobacillus, 
member of Rikenellaceae family
 KEGG pathways: ↑methane and 
dibasic acid, aromatic amino acid 
metabolism
DHA supplementation:
 ↓ EPM anxiety and anhedonia
 ↓Lactococcus and Leuconostoc
↑Streptococcus and Helicobacter
 KEGG pathways: ↑tyrosine and 
glutathione metabolism, and 
unsaturated fatty acid biosynthesis 
 ↑Allobaculum, ↓Ruminococcus 
COR ↑open arm entry and sucrose 
consumption
Social isolation: 
 ↑Clostridia class (Clostridium, 
Ruminococcus, Coprococcus, 
Anaerotruncus) 
 KEGG pathways: ↑bacterial 









RNA microarray Illumina 
BeadArray Scanner 500GX.
RNAseq-Illumina HiSeq 2000.
GF compared to SPF:
 E18.5 SSC: 1216 DEGs, mostly ↓
 E18.5 neocortex: ↑microglia
 P60 SSC: 26 DEGs, ↑ microglia
#No sex-difference in human mid-
trimester foetal microglia.
 E18.5 control F vs M: ↑ DEGs 
associated with inflammation, 
apoptosis, LPS response
GF compared to SPF:
 E18.5 SSC: 20 DEGs
 P20 neocortex: ↑microglial
 P60 SSC: 433 DEGs (associated 






1-week ABX in sterile drinking 
water (ampicillin, colistin, 
streptomycin, amphotericin). 
RNAseq- Illumina NextSeq 500.
 92 microglia genes regulated
(63 immune response)
 No effect on microglial density or 
morphology









GF + Colonization at P21 
(ExGF)
Hpc: MicroRNA microarray, 
Exiqon.
PFC: RNAseq Illumina 
NextSeq500.
GF: X body weight
 ↓LD anxiety (rescued with 
colonization)
 Plasma: ↑Trp, ↓Kynurenine/Trp 
(rescued)
 Hpc: ↓Bdnf, ↑ serotonin, 5-HIAA
 PFC: ↑miR-294-5p (rescued)
 PFC: 190 DEGs, ↑ myelination- 
and activity-related genes




 Plasma: ↓kynurenine/ Trp
 Hpc: ↓5-HT2C
 PFC: X miR-294-5p
 No change in brain myelination.





















GD14-P3-Ampicillin ABX in 
drinking water.
Peptidoglycan sensing molecule 
gene in controls:
 P3 PFC: F>M
 P3 Striatum: M>F
 P14 Striatum:  F>M
 GF/ABX: ↓PGN, Region-specific
KO:
 P3: ↓striatal Bdnf
 Juvenile: ↑social interaction
               ↑ striatal c-Met
 15 months: ↓anxiety-like behaviour
                   ↓amygdalar α-synuclein
 GF P3: ↑striatal synaptophysin
KO:
 P3 PFC: ↑ synaptophysin
 P3 Striatum: ↑synaptophysin
                     ↓c-Met
 Juvenile Amygdala: ↑c-Met
 15 months: 













2-week vancomycin or 
ciprofloxacin-metronidazole in 
drinking water at 8 weeks of age. 
16S Illumina HiSeq2500.
Vancomycin:
 ↑Morganella, Sutterella, Proteus
 Colonic content: ↑lactate, ↓tyrosine
Ciproflaxin-metronizodale:
 Colonic content: ↓ lactate
 X Shannon index, SCFA
Vancomycin: 




 Similar effects to vancomycin








8- 21 week- Manganese exposure 
(MnCl2 in drinking water). 
16S Illumina MiSeq. Metagenomic 
Illumina NextSeq. Faecal 
metabolomics.
 ↓ Sex difference in bacterial genes
 Gut microbiota: 
↑Firmicutes, Tenericutes
↓Bacteroidetes, Verrucomicrobia 
 ↓ Microbiota genes: 
GABA, phenylalanine, and lipid 
synthesis genes, antibiotic 





 ↑ Microbiota genes: 
Phenylalanine, LPS, lipid synthesis 
genes, DNA repair genes, antibiotic 






HFD + Arachidonic Acid
4-week old: High fat diet (HFD) for 
10 weeks, and continued HFD +/-
Arachidonic acid (AA) for 15 
weeks. 16S Illumina MiSeq.
 HFD: ↑caecal SCFA content
HFD+AA:
 Microbiota COR ↑obesity, 
inflammation
 Hypothalamus: ↑inflammation and 
microglia, ↑AGRP, NPY
↓POMC, LEPR
 Caecum: ↑acetate ↓butyrate
 HFD: ↓caecal SCFA content
HFD+AA:
 ↑Proteobacteria ↓Verrucomicrobia 
phylum, shifts microbiota 
composition towards protective 
functions, ↓inflammation, ↑SCFA 
producers
 Hypothalamus:
↓AGRP, ↑LEPR and GRP109A










BTBR compared to C57BL6/J.
16S Illumina MiSeq.
 167 OTUs different
 ↑Lactobacillus, ↓Desulfovibrio
 Colon: ↑IL-6 and Cd11c gene 
expression
 245 OTUs different









model of Aβ 
amyloidosis)
7 weeks
Aβ amyloidosis + ABX
ABX (kanamycin, metronidazole, 
colistin, gentamicin, vancomycin): 
P14-P21 gastric gavage and P21- 
1:50 in drinking water. 
Rescue: Control FMT-gavage daily 
P25 till 7 weeks + 1:50 ABX.
16S Illumina MiSeq.
Cortex of model alone:
 Aβ deposition, microglia size M>F
ABX:
 Plasma: ↓pro-inflammatory 
markers, ↑anti-inflammatory/ 
neuroprotective markers
 Cortex: ↓Aβ deposition
↑TGFβ pathway genes
 Several effects rescued by FMT
ABX:
 ↑Akkermansia muciniphila and an 
Allobaculum spp. cluster, ↑pro-
inflammatory pathways (F>M)
 Plasma: ↑pro-inflammatory 
markers












SPF, GF and F1 Gnotobiotic
F1 Gnotobiotic mice from GF: 
Colonized with VSL3*, 
SFB: segmented filamentous 
bacteria, SECS: Proteobacterium 
sequence similar to E. coli /Shigella 
isolated from ♂. 16S Roche 454 
FLX Pyrosequencing.
 SFB: ↓T1D markers
 Con, SFB, SECS compared to GF: 
Serum: ↑ testosterone
Pancreatic lymph nodes: 
             ↑activated macrophage
             ↑IFNγ (T-cells) and IL-1
 Heat-inactivated SECS exposed 
macrophages: ↑T-cell IFNγ
 SPF insulitis: F>M
 GF/ ♂castration: attenuates sex-
difference T1D
 Gnotobiotic: No changes seen in 
any groups
*VSL3 mix: Bifidobacterium breve, B. 
longum, B. infantis, Streptococcus 
thermophilus, Lactobacillus bulgaricus 














Serum metabolite kit: 
AbsoluteIDQ® p180 Kit, 
Biocrates Life Science AG.
FMT: Adult M→SPF weaned F
+ Androgen receptor (AR) 
antagonist (flutamide) 
Microbiome: regulate testosterone, 
anti-inflammatory T cells and 
protects against T1D in adult life.
 SPF M<F
Insulitis 
Serum: ↑ lysine, Trp amino acid
 GF: attenuates sex-difference T1D 
Serum: 
        ↑several serum amino acids
   (greater difference than between ♀)
        ↓testosterone
        No effect on 17β-oestradiol
 GF+ASF: Restores sex-bias in T1D
 GF: ↑ serum testosterone
 FMT: 
Serum: ↑testosterone, ↓sphingolipid
            ↓glycerophospholipid
↓T1D relative to F→F recipients 
(not observed at 34 weeks)










P2-P14 maternal separation (MS) 
and Lactobacillus in water.
MS: delayed puberty reversed by 
probiotics












P3, P5- LPS i.p. 
P72-78-ABX enrofloxacin. 
Faecal samples- P24, 
pre-ABX P71, during ABX P78, 
post-ABX P85.
16S Illumina MiSeq.
 LPS: No effect on male 
reproductive physiology, adult 
microbiome







↓% regular oestrus cycling F
↓Corynebacteriaceae, 
↑Ruminococcaceae














GF male versus female
Serum BA, ileum gene microarray.
16S Illumina MiSeq.
 GF: ↑ BA transporter gene
       ↓ BA binding protein
       ↓ Basolateral BA transporter
 Con: ↑ LDL receptor gene
 GF: ↓sex difference in ileal genes
 GF and Con: ↑total and 1˚ BA







Gonadectomy (GDX) + HFD
HFD: high-sucrose-high-fat diet, 
gall bladder bile composition.
 ↑BA (M>F)
 ↑a- and b-Murincholic acid
 ↓c-Murincholic acid









Western diet: wean-20 weeks.
ABX (ampicillin, vancomycin, 
neomycin, metronidazole): 
20-26 weeks (2x/ day) oral gavage.
WD: ↑Metabolic syndrome (MeS)
 ↑ obesity
 ↑ Intestinal permeability
 ↑ Glucose intolerance
 Serum: ↑LPS,LBP,TNFα,IL1β,IL6
All Rescued by ABX
 WD: MeS less severe compared to 
♂ 
 WD+ABX: 
Only impaired glucose tolerance
Alleviated sex difference in MeS
(Kaliann







Western diet: wean-20 weeks.
10-week- ovariectomy.
11-17-week oestradiol in water.
 WD+Oestradiol: Rescued MeS
 WD+OVX: ↑obesity, MeS markers 
 (Rescued by Oestradiol)
 At 3 weeks single WD ♂to ♀ FMT: 
↑obesity and MeS
(Kaliann






♂ WD + Oestrogen mimetic
4-month male: 5-week isoflavones 
(ISO, oestrogen mimetic) genistein 
and daidzein. 16S Illumina MiSeq.
 Rescue MeS
 Gut: ↑ERα mRNA levels, ↑alkaline phosphatase activity
 Microbiome:↓Proteobacteria, ↑Akkermansia, Bifidobacterium, Bacteroides
 Altered bacterial gene pathways: ↓LPS synthesis, ↑amino acid metabolism
Kalianna
n et al. 
2018)
5-HIAA- 5-hydroxyindole acetic acid, AA- Arachidonic acid, Aβ- Amyloid beta, ABX- Antibiotic, AGRP- Agouti-related peptide, AR- Androgen receptor, 
ASF- Altered Schaedler's flora (two Lactobacilli, one Bacteroides, one spiral bacteria of Flexistipes, and four obligate anaerobic Fusobacterium species), BA- 
Bile acid, Bdnf- Brain derived neurotrophic factor, c-Met- tyrosine-protein kinase Met/ hepatocyte growth factor receptor (proto-oncogene), COR- correlated, 
Con- Conventional, CUS- Chronic unpredictable stress, DEGs- Differentially expressed genes, E- Embryonic day, EPM- Elevated-plus maze test, F/B- 
Firmicutes to Bacteroidetes ratio, FMT- Faecal microbiota transfer, FST- Forced-swim test, GABA- γ-amino-butyric acid, GD- Gestation day, GDX- 
Gonadectomised, GF- Germ-free, GRP109A- G-protein-coupled receptor 109A, Hpc- Hippocampus, IFN-Interferon, IgA- Immunoglobulin A, IL-Interleukin, 
i.p.- Intraperitoneal, LD- Light dark box test, LDL- low density lipoprotein, LEPR- Leptin receptor gene, LPS- Lipopolysaccharide, MeS- Metabolic syndrome, 
MIA- Maternal immune activation, MS- Maternal separation, NPY- Neuropeptide Y gene, OFT- Open-field test, OTUs- operational taxonomic units, OVX- 
Ovariectomised, P-Postnatal day, PFC- Prefrontal cortex, Pglyrp- Peptidoglycan recognition protein, PGN- Peptidoglycan, POMC- Pro-opiomelanocortin, 
PVN- Paraventricular nucleus of hypothalamus, s.c.- Subcutaneous, SCFA- Short chain fatty acid, SECS- Proteobacterium sequence similar to E. coli /Shigella, 
SFB- segmented filamentous bacteria, SPF- Specific pathogen free, T1D- Type 1 diabetes, TNF-α- Tumour necrosis factor α, WD- Western diet.
57
Highlights
1) Male brain is particularly vulnerable to microbiota-based insults in early life.
2) Subtle differences in male and female gut microbiome.
3) Microbiota influences sex hormone conjugation and bile acid levels.
4) Microbiota and sex hormones can regulate inflammatory and metabolic factors.
5) Gut microbiota enhances sex difference on a variety of physiological measures.
